European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% higher to 1,839.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biopharmaceutical company DBV Technologies (DBVT), which rose 2.6% and 2.1%, respectively. They were followed by biotech firm Evaxion (EVAX) and pharmaceutical company Sanofi (SNY), which were up 1.9% and 1.1%, respectively.

The decliners from continental Europe were led by telecommunications operator Telefonica (TELFY) and pharmaceutical company Novo Nordisk (NVO), which dropped 3.8% and 2.4%, respectively. They were followed by lender Banco Santander (SAN) and telecommunications company Nokia (NOK), which lost 1.9% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which advanced 7.8% and 6.1%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which increased 5.5% and 5.1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and lender Lloyds Banking Group (LYG), which fell 2.9% and 1.3%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and tobacco company British American Tobacco (BTI), which were down 1.1% and 0.9%.